ern blot analysis or long-polymerase chain reaction (PCR) as described previously (17) . For Southern blot analysis, EcoRI or EcoRI/BlnI digested genomic DNA was separated by gel electrophoresis and then the DNA was transferred to Hybond XL (Amersham Biosciences, Piscataway, NJ, U.S.A.). After hybridization with radioisotope labeled p13E-11 equivalent PCR probe, the EcoRI and EcoRI/BlnI allele sizes were analyzed (18) . Long-PCR detection of shortened D4Z4 repeats was performed for patient 3 because the genomic DNA was not enough for conventional Southern blot analysis. All conditions and primer sequences for long-PCR was described previously and a positive control with 2 D4Z4 repeats and a negative control were tested in parallel (19) .
RESULTS

Clinical findings
Patient 1 was a 30-yr-old woman complaining of progressive limb muscle weakness. She was in good health until age 12 yr, at which time she began to have a difficulty in raising her right arm above her head. Later, she developed increasing difficulties climbing stairs. By report, her mother had similar symptoms from the age of 40. His 35-yr-old brother was not affected clinically (Fig. 1A) . The neurological examination was remarkable for moderate facial weakness; moderate (Medical Research Council [MRC] grade 3) and mild (MRC grade 4) weakness of proximal upper and lower limb muscles, respectively; humeral atrophy; anterior axillary folds; winged scapulae; waddling gait; and hypoactive deep tendon reflexes. The serum creatine kinase (CK) was 233 IU/L (normal, <270 IU/L). Other routine laboratory tests including thyroid and parathyroid function were normal. Audiogram, electrocardiogram, echocardiogram, nerve conduction studies were unremarkable. Needle electromyography showed chronic myopathic changes in the left deltoid, biceps brachii, and vastus lateralis muscles. A muscle biopsy from the right vastus lateralis revealed marked fiber size variations, increased internalized nuclei, endomyseal fibrosis and fat ingrowth, and frequent lobulated myofibers.
Patient 2 was a 36-yr-old man presenting with progressive limb muscle weakness, which developed at the age of 20. Initially, he began to have a difficulty in raising his arm above his head and climbing stairs. The weakness was slowly progressive. His mother was noted to have similar symptoms (Fig. 1B) . His 34-yr-old brother and 39-yr-old sister were not affected clinically. The neurological examination was remarkable for moderate facial weakness; mild (MRC grade 4) and minimal weakness of proximal and distal extremity muscles, respectively; and humeral and quadriceps atrophy. Other remarkable findings included winged scapulae, anterior axillary folds, waddling gait, and hypoactive deep tendon reflexes. The serum creatinine kinase (CK) was 610 IU/L. The forced vital capacity (FVC) was 3.2 L (71% of predicted). Electrocardiogram, echocardiogram, audiogram, and nerve conduction studies were normal. Needle electromyography demonstrated chronic myopathic changes.
Patient 3 was an 18-yr-old man complaining of progressive right upper limb weakness over the prior 3 yr. The initial diagnosis was idiopathic right brachial plexopathy. He was a tennis player in his early teens. There was no family history of neuromuscular disease ( He first noticed a difficulty in raising his arm above his head. There was no known family history of neuromuscular disease in his parents, five sibs, and two daughters (Fig. 1D) . The neurological examination was remarkable for mild (MRC grade 4) weakness of proximal upper limb muscles and humeral atrophy. Other remarkable findings included anterior axillary folds, asymmetric winged scapulae, trapezius hump sign, Beevor's sign, and hypoactive deep tendon reflexes. There was no facial weakness. The serum CK was 170 IU/L. The FVC was 4.19 L (87% of predicted). Electrocardiogram, echocardiogram, and nerve conduction studies were normal. Needle electromyography showed chronic myopathic changes.
Genetic analysis and genotype-phenotype correlations
All four patients were demonstrated to have shortened D4Z4 repeats. Patients 1, 3, and 4 had 4, 6, and 7 repeats of D4Z4 segment confirmed by conventional Southern blot, respectively (Fig. 2 ). Patient 2 was tested by long-PCR that he had 3 D4Z4 repeats (Fig. 3) . When we tested both parents of the patient 3, they did not have shortened D4Z4 repeats suggesting a de novo mutation occurred in patient 3. Since the mothers of patients 1 and 2 were not tested genetically, we could not confirm the inheritance of pathogenic D4Z4 repeats in these families.
In the four patients in our study, the tendency of inverse correlation between clinical severity and D4Z4 repeat number was suggested. However, similar tendency was not found between age of onset and D4Z4 repeat number (Table 1) .
DISCUSSION
To date, the diagnosis of FSHD was usually made on the basis of clinical findings in Korea. Although individual patients with FSHD may vary to some extent, most of the patients fit into a clinically typical feature. However, with the availability of genetic testing, it has been recently reported that the clinical manifestations of FSHD are much broader than previously known (6) (7) (8) (9) (10) (11) . Therefore, it can be misleading to make a diagnosis solely based on the clinical findings especially in the patient with atypical presentations. In our study, two patients showed unusual clinical features. The initial diagnosis of patient 3 was idiopathic brachial plexopathy due to right arm weakness, asymmetric winged scapulae, and a negative family history. In patient 4, facial weakness and family history were absent. Furthermore, other tests including serum CK, needle electromyography, and muscle biopsy often do not helpful in the diagnosis of FSHD, as in our patients. Therefore, genetic testing is essential to confirm the correct diagnosis of FSHD. And it will be also helpful to facilitate the diagnosis and avoid unnecessary tests, especially in the patient with atypical presentations.
Molecular diagnosis for FSHD is used for diagnostic confirmation, pre-symptomatic testing, and for prenatal diagnosis. FSHD diagnosis relies on the detection of a D4Z4 repeat array less than 35 kb (<10 units) (20) . However, a number of factors have complicated the molecular diagnosis of FSHD (13) . First, it was reported that a highly homologous and equally polymorphic repeat resides on chromosome 10. Second, in nearly one-fifth of all individuals, exchanges of repeat units have been observed between chromosomes 4 and 10. A third complication comes from the observation of a biallelic variation of chromosome 4qter, designated 4qA and 4qB. It is reported that FSHD is associated solely with the 4qA allele and contractions of D4Z4 on 4qB subtelomeres do not cause FSHD (21, 22) . Furthermore, a minority of patients carries a contraction of D4Z4 that extends in a proximal direction. The disease allele in these patients often goes undetected, as the probe region is also missing from the disease allele. Lastly, locus heterogeneity still remains. Nonetheless, Southern blot analysis using two restriction enzymes discriminating 4-type and 10-type units are very useful that FSHD can be diagnosed with up to 98% accuracy (23) .
Recently, a new diagnostic method for rapid and specific diagnosis of FSHD by a long PCR has been introduced (19) . This long PCR method can specifically amplify the repeated region from chromosome 4q up to 18.4 Kb in size and countable from one to five D4Z4 repeated units. By using this new technique, we can confirm a diagnosis of FSHD in one patient in whom we could not perform conventional Southern blot analysis due to insufficient DNA. Although Lemmers et al. (24) argued that at least half of the Caucasian FSHD patients could not be diagnosed by the long PCR method because of the different distribution of D4Z4 repeats alleles in Japanese and in Caucasians, this method might be useful when the conventional Southern blot analysis is unavailable. Nevertheless, careful attention should be made to prevent false-negative results by long PCR method because of amplification failure due to 5 or more D4Z4 repeats.
Penetrance of FSHD was found variable by age and gender that it was 83% by age 30 yr and males were reported to be more severely and more frequently affected than females (95% vs. 69%, respectively) (25) . Anticipation in FSHD remains controversial, but an inverse correlation between D4Z4 repeat size and the clinical severity and onset age was reported (4, 5) . A similar result was suggested only in the clinical severity in our study. However, the number of the patients in our study was too limited to clearly verify a relationship between the clinical features and D4Z4 repeat size. Further study in a larger number of the FSHD patients is needed.
This study reports four patients with genetically established FSHD. Two of them had family histories while the others did not. Considering that genomic structure of D4Z4 repeat in chromosomes 4 and 10 in Koreans is similar to that in Japanese, the frequency of FSHD might not be different from that in Japan (26) . However, there are only limited reports on the FSHD in Korea (14, 15) . Therefore, more efforts should be made to identify and to diagnose Korean patients with FSHD by genetic analysis.
